In contrast to in vitro growth, we noticed that silencing AHCYL1 boosted tumor development (Figure 3(b)) and raised tumor weight (Figure 3(c)) much more than cells expressing ctrl shRNA. The gene discussed is AHCYL1; the disease is neoplasm.